Última Hora: "7,2 milhões de utilizadores em Portugal utilizam Internet móvel - TugaTech" Sat, 17 Nov 2018 11:47:07 GMT    "Viagem pelos tascos e papelarias que servem o correio dos CTT - Jornal de Negócios - Portugal" Sat, 17 Nov 2018 10:43:00 GMT    "CEO do Banco CTT: OE olha para défice mas é "pouco ambicioso" para empresas - Jornal de Negócios - Portugal" Sat, 17 Nov 2018 21:01:55 GMT    "As nossas democracias vão acabar? - Jornal de Negócios - Portugal" Thu, 15 Nov 2018 19:17:12 GMT    "Primeiro autocarro ?urbano eléctrico? da AveiroBus vai para a estrada no início da semana - Diário de Aveiro" Sat, 17 Nov 2018 06:02:16 GMT    "Morreu o dono de um carro com? 5,15 milhões de km! - Observador" Sat, 17 Nov 2018 18:23:00 GMT    "?Mário, o cativador?: o cognome do Ministro das Finanças segundo o PSD - Expresso" Sat, 17 Nov 2018 21:45:40 GMT    "Preços dos combustíveis descem na segunda-feira - TVI24" Sat, 17 Nov 2018 22:18:09 GMT   "" Sun, 18 Nov 2018 01:26:40 GMT    "Portuguesa Tonic App chega ao pódio mundial e ganha aconselhamento da Bayer - Jornal de Negócios - Portugal" Sat, 17 Nov 2018 17:04:00 GMT      Para mais notícias, clique aqui.

Área de Acesso
       
       
Lembrar Sempre 
(Login BolsaPT & Canal Forex)

Queda de
--59.00 (+0.83%) SCHERING PLOUGH C - [Ticker: SGP]Gráfico SCHERING PLOUGH C  Notícias SCHERING PLOUGH C  Download de Históricos Metastock SCHERING PLOUGH C e Outros  Análise Técnica SCHERING PLOUGH C  
Última Trade290,000Range 52 Semanas[0,000 - 0,000]
Hora da Última Trade2018-11-13 - 00:00:00Price-Target 1 Ano0,000
Variação--59.00 (+0.83%)Capitalização Bolsista0
Bid / AskN/AEPS0,00
Abertura290,200PER0,00%
Máximo290,200Pagamento Dividendo
Mínimo290,000Data Ex-Dividendo
Fecho Anterior349,000Yield
Volume160Volume Médio (3m)0
Nota: Os dados podem apresentar atraso de alguns minutos.
Ver cotações de outros activos

Intraday   5 dias   1 mes   3 meses   6 meses   1 ano   2 anos   5 anos   10 anos            Use este gráfico no seu website!
Gráfico de SCHERING PLOUGH C -  [Ticker: SGP]
Mudar para Gráfico de Análise Técnica Interactiva de SCHERING PLOUGH C

Últimos 10 Tópicos no Fórum sobre SCHERING PLOUGH C:
Não foram encontrados tópicos sobre SCHERING PLOUGH C [SGP], mas aconselha-se pesquisa no Fórum por tópicos relacionados com SCHERING PLOUGH C.

 Notícias sobre SCHERING PLOUGH C [SGP]:   (ordenadas por relevância)

BioTelemetry, Inc. Elects Stephan Rietiker to its Board of Directors
Nasdaq
Prior to becoming CEO of LifeWatch AG in 2014, Dr. Rietiker held executive roles at Roche, Boehringer Mannheim, Schering Plough, Covance and as CEO of Centerpulse (formerly Sulzer Medica). Additionally, he has been an investor, executive and Board ...

e mais »

Snelson Named AASV New Executive Director
Pork Magazine
For the first time in 25 years, the American Association of Swine Veterinarians (AASV) will have a new Executive Director, Dr. Harry Snelson. Snelson, who is the current AASV Director of Communications, has had a long association with the organization ...


Crypto News

Antibiotics Drugs Market 2018 | Top Vendors- Glaxo Smithkline ...
Crypto News
The key players covered in this report: , Glaxo Smithkline, Johnson & Johnson, Sanofi-Aventis, Enanta Pharmaceuticals, Bayer Schering Plough, Merck, Pfizer, Wyeth Pharmaceuticals, Novartis International, Lg Life Sciences. This research study involved ...

e mais »

National Hog Farmer

Snelson named AASV executive director
National Hog Farmer
... Medicine and then spent 10 years as the swine veterinarian for Carroll's Foods in Warsaw, N.C. In 2000, he accepted a position as a swine technical services veterinarian with Schering-Plough Animal Health before leaving in 2003 to become the ...


Global Interferon Biosimilar Market Revenue, Key Factors Analysis ...
Digital Journal
Biosidus. Zydus Cadila. Nanogen. Amega Biotech. Rhein Minapharm Biogenetics. PROBIOMED. 3sbio. Amgen. Bayer. Schering Plough. Merck. Market Segment by Product Type. Long-lasting Type. Ordinary Type. Market Segment by Application. Hepatitis C.

e mais »

Interferon Biosimilar Market Business Outlook and Global Insights ...
thestocknewsnow.com
The Global Interferon Biosimilar Market Research Report Forecast 2018-2025 is a valuable source of insightful data for business strategists. It provides the industry overview with growth analysis and historical & futuristic cost, revenue, demand and ...

e mais »

Interferon Biosimilar Market Growth Rate at CAGR(%) and Regional ...
Industry Today (press release)
Zydus Cadila. Nanogen. Amega Biotech. Rhein Minapharm Biogenetics. PROBIOMED. 3sbio. Amgen. Bayer. Schering Plough. Merck. Market Size Split by Type. Long-lasting Type. Ordinary Type. Market Size Split by Application. Hepatitis C. Hepatitis B.

e mais »

LANews By Abhishek Budholiya (press release) (blog)

Anti-Viral Drugs Market Is Expected To Generate Huge Profits by ...
LANews By Abhishek Budholiya (press release) (blog)
Based on product type, the global anti-viral drugs market is segmented into the following:Hepatitis-C antivirals,HIV antivirals,Herpes antivirals,Hepatitis-B antivirals,Influenza antivirals,Others (Pneumonia, Flu, etc.). ... Some of the key players in ...


DOF: 16/11/2018
Diario Oficial de la Federacion (Comunicado de prensa)
01 004051 GAMESA, SALADAS, CRACKETS, CAJA C/6 ROLLOS DE 417 GR 67.15 KG CAMBIO DE PRESENTACION. 01 004062 ...... 11 197004 CLARITYNE, TABLETAS, 10, DE 10 MG, LAB SCHERING PLOUGH 112.50 CAJA CAMBIO DE MARCA.


Global Interferon Biosimilar Market 2018-2025 Roche, Biosidus ...
chemicalindustry24.com
Global Market Study Interferon Biosimilar Market Provide Forecast Report 2018 ? 2025 presents an detailed analysis of the Interferon Biosimilar which researched industry situations, market Size, growth and demands, Interferon Biosimilar market outlook, ...

e mais »

??????? (????)

??? ???? ?, ??? ?? ???? 10?
??????? (????)
??????? ???? ?? ??? ????? ? ?? C??? ???? ????? ??? ??? ?? ???. ?? ??? ???? Wnt ?????? ???? ??? ???? ???. ? ??? ?????(Schering-Plough, S-P)?? ??? ?? ??? ...


Anti-Viral Drugs Market Capital to Gain Maximum Attention ...
Redfield Herald (press release) (blog)
The report includes the forecasts, Analysis and discussion of important industry trends, market size, market share estimates and profiles of the leading industry Players: ,Schering-Plough ,Gilead ,AstraZeneca ,Cipla ,Rocheerck & Co ,Bristol-Myers ...


Reuters

Keytruda sales power Merck to quarterly beat
Reuters
(Reuters) - Drugmaker Merck & Co (MRK.N) reported better-than-expected first-quarter earnings on Tuesday, helped by a more than 150 percent rise in sales of blockbuster cancer drug Keytruda.


The Pharmaceutical Journal

Hepatitis C: tackling the silent killer
The Pharmaceutical Journal
1997: The first alpha interferon, Schering-Plough's Intron A (interferon alpha-2B), is approved for treatment of hepatitis C in the UK. 1999: European blood services begin screening blood with nucleic acid amplification testing (NAT), because it ...


Merck, Schering-Plough set to complete merger
Reuters
NEW YORK (Reuters) - Merck & Co (MRK.N) and Schering-Plough Corp SGP.N said their $41.1 billion merger will be completed later on Tuesday, marking the close of the second huge deal in the pharmaceutical industry in recent weeks. Pfizer Inc (PFE.

Para mais notícias sobre SCHERING PLOUGH C clique aqui:
Notícias de SCHERING PLOUGH C

Largura do Site:

 Imagem de Fundo:

Copyright@1998-2018 - BolsaPT.com, todos os direitos reservados.
Fórum de Bolsa Cotações de Bolsa Notícias de Bolsa Chat de Bolsa Disclaimer Recursos para Webmasters